The Biodiagnostica Montevergine Malzoni Network in Mercogliano will introduce Proclarix® into its laboratory routine
News 11.05.2022 Zurich-Schlieren, Switzerland and Avellino, Italy, May 11, 2022 – Diagnostica Medica of Mercogliano (Avellino), Italy, and Proteomedix, the Swiss cancer diagnostics company, announced today that Proclarix®, a new blood test for the management of prostate cancer patients, has been introduced in the routine of the laboratory that is part of...